Amlodipine Besylate And Atorvastatin Calcium
Product Images NDC 54868-6335

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Atorvastatin Calcium (NDC 54868-6335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (10 mg/80 mg Tablet Label)

The text appears to be a medication label that includes the drug combination Amlodipine/Rosuvastatin 16mg/80mg. The label also has a code, KDC S485E-6335-6 38 TRB, and two numbers, 9583 and 8180, which may be related to the medication's batch and expiration date.*

FDA Label Image

Chemical Structure (Amlodipine 01)

FDA Label Image

Chemical Structure (Amlodipine 02)

FDA Label Image

Figure 1 (Amlodipine 03)

This text appears to be a table displaying event rates and statistical data for a study involving a medication called "Amiadipine" versus a placebo. The table includes columns for Event Rate, P-value, Hazard Ratio, and 95% confidence interval. The data in the Event Rate column ranges from 0.05 to 0.20. The P-value is listed as 0.003 and the Hazard Ratio is 0.691. The 95% confidence interval is between 0.54 and 0.88. There is also a column for time in months, ranging from 12 to 24. There is not enough information to determine the purpose of the study or the precise nature of the event rates being measured.*

FDA Label Image

Figure 2 (Amlodipine 04)

This appears to be a summary of some kind of medical study or trial involving patients with a certain condition, with a focus on the use of stent placement during PCI (percutaneous coronary intervention, a type of procedure used to treat narrowed or blocked arteries in the heart). The text includes some numerical data related to the study, but the meaning or significance of these numbers is not clear from just this text, and some of the words and characters are not readable.*

FDA Label Image

Figure 3 (Amlodipine 05)

The text represents a graph showing the cumulative incidence of a condition or disease for patients who were treated with Atorvastatin and those who received the placebo. The incidence is shown as a percentage over a period of up to 35 years. Atorvastatin is associated with a lower incidence of the condition, as indicated by the Hazard Ratio (HR) of 0.64 and a statistically significant p-value of 0.0005. There are no details about the nature of the condition or the study population.*

FDA Label Image

Figure 4 (Amlodipine 06)

FDA Label Image

Figure 5 (Amlodipine 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.